EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modular cytosine base editing promotes epigenomic and genomic modifications

Julian Weischedel, Laurence Higgins, Sally Rogers, Anna Gramalla-Schmitz, Paulina Wyrzykowska, Simone Borgoni, Thomas MacCarthy, Richard Chahwan iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkad1118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Julian Weischedel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland. Hauptthemen laut MEDLINE: Cytosine Deaminase, Gene Editing. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SNF, Novartis Foundation, Vontobel Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prokaryotic and eukaryotic adaptive immunity differ considerably. Yet, their fundamental mechanisms of gene editing via Cas9 and activation-induced deaminase (AID), respectively, can be conveniently complimentary. Cas9 is an RNA targeted dual nuclease expressed in several bacterial species. AID is a cytosine deaminase expressed in germinal centre B cells to mediate genomic antibody diversification. AID can also mediate epigenomic reprogramming via active DNA demethylation. It is known that sequence motifs, nucleic acid structures, and associated co-factors affect AID activity. But despite repeated attempts, deciphering AID’s intrinsic catalytic activities and harnessing its targeted recruitment to DNA is still intractable. Even recent cytosine base editors are unable to fully recapitulate AID’s genomic and epigenomic editing properties. Here, we describe the first instance of a modular AID-based editor that recapitulates the full spectrum of genomic and epigenomic editing activity. Our ‘Swiss army knife’ toolbox will help better understand AID biology per se as well as improve targeted genomic and epigenomic editing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytosine DeaminaseGene EditingCRISPR-Cas SystemsCytosineEpigenomicsRNACRISPR-Associated Protein 9AICDA (Activation-Induced Cytidine Deaminase)

Substanzen

CytosineCytosine DeaminaseRNAAICDA (Activation-Induced Cytidine Deaminase)CRISPR-Associated Protein 9

Autor:innen und Institutionen

  • Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.
  • Living Systems Institute, University of Exeter, Exeter EX4 4QD, UK.
  • Department of Applied Mathematics & Statistics, Stony Brook University, NY 11794-3600, USA.

ORCID-Profile: Richard Chahwan

Förderung

  • SNF
  • Novartis Foundation
  • Vontobel Stiftung
  • UZH
  • UZH-URPP
  • Translational Cancer Research
  • Swiss Excellence Scholarship
  • Functional Genomics Center Zurich

Zitieren

APA

Weischedel, J., Higgins, L., Rogers, S., Gramalla-Schmitz, A., Wyrzykowska, P., Borgoni, S., MacCarthy, T., & Chahwan, R. (2024). Modular cytosine base editing promotes epigenomic and genomic modifications. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1118

Vancouver

Weischedel J, Higgins L, Rogers S, Gramalla-Schmitz A, Wyrzykowska P, Borgoni S, et al. Modular cytosine base editing promotes epigenomic and genomic modifications. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1118

BibTeX
@article{Weischedel2024,
  author = {Weischedel, Julian and Higgins, Laurence and Rogers, Sally and Gramalla-Schmitz, Anna and Wyrzykowska, Paulina and Borgoni, Simone and MacCarthy, Thomas and Chahwan, Richard},
  title = {Modular cytosine base editing promotes epigenomic and genomic modifications},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkad1118}
}
Kostenlos starten →